The microbiome represents a paradigm shift that affects every aspect of biomedicine: our gut bacteria control health, disease and drug response throughout the body, and can themselves be a novel type of medicine. The microbiome therefore has the potential to be a major new therapeutic modality.
Microbiotica was founded by Dr Trevor Lawley, Prof Gordon Dougan FRS and Dr Mike Romanos in December 2016 to exploit fundamental adva...
The microbiome represents a paradigm shift that affects every aspect of biomedicine: our gut bacteria control health, disease and drug response throughout the body, and can themselves be a novel type of medicine. The microbiome therefore has the potential to be a major new therapeutic modality.
Microbiotica was founded by Dr Trevor Lawley, Prof Gordon Dougan FRS and Dr Mike Romanos in December 2016 to exploit fundamental advances made at the Sanger Institute to address barriers to the translation of the microbiome.
A central premise has been that a more rigorous and comprehensive analysis.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.